Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study.

Journal: The lancet. HIV

Publication date: 2023

Journal: The lancet. HIV

Publication Year: 2023

Authors & Co-authors:  Brooks Kiser Ziemba Ward Rani Cressey Masheto Cassim Deville Ponatshego

Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial.

Journal: The lancet. HIV

Publication date: 2022

Journal: The lancet. HIV

Publication Year: 2022

Authors & Co-authors:  Ruel Acosta Liu Gray George Montañez Popson Buchanan Bartlett Dayton